Related Experiment Videos
Pyrin/marenostrin mutations in familial Mediterranean fever
D R Booth1, J D Gillmore, S E Booth
1Immunological Medicine Unit, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
Abstract:
Familial Mediterranean fever (FMF) is an inherited inflammatory disease that is frequently complicated by reactive systemic (AA) amyloidosis. It is principally recognized in certain Mediterranean populations, and the diagnosis depends on clinical features. Four mutations strongly linked to FMF have lately been identified in a gene encoding a novel protein that has been named pyrin or marenostrin. We studied 27 consecutive patients of varied ethnic origin, including an English man, who had classical, probable or possible FMF. Pyrin/marenostrin genotypes were determined, and AA amyloidosis was sought using serum amyloid P component scintigraphy. Among the 23 patients with classical or probable FMF, 17 were homozygotes or compound heterozygotes for pyrin/marenostrin mutations, and in five, only single allele mutations were identified. Two new mutations, T6811 and delta M694, were discovered in addition to the four described previously. No mutations were identified in three of the four patients with possible FMF. Nine patients had AA amyloidosis, but this association was not restricted to any particular genotype. Most patients with FMF have mutations in both pyrin/marenostrin alleles, and genotyping at this locus is a valuable diagnostic test. Unidentified second mutations are likely to occur in FMF patients who have apparently solitary mutations, and therefore genotype results must be interpreted in conjunction with the clinical picture.
Insights
Familial Mediterranean fever (FMF) genetic testing identifies mutations in the pyrin/marenostrin gene. Genotyping is a valuable diagnostic tool for FMF, aiding in the diagnosis of this inherited inflammatory disease.
Area of Science:
- Genetics
- Immunology
- Internal Medicine
Background:
- Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder.
- FMF is often complicated by reactive systemic amyloidosis (AA amyloidosis).
- Pyrin/marenostrin gene mutations are strongly linked to FMF.
Purpose of the Study:
- To investigate the genetic basis of FMF in a diverse patient cohort.
- To correlate pyrin/marenostrin genotypes with FMF clinical phenotypes and AA amyloidosis.
- To evaluate the diagnostic utility of pyrin/marenostrin genotyping in FMF.
Main Methods:
- Studied 27 patients with classical, probable, or possible FMF.
- Determined pyrin/marenostrin genotypes.
- Assessed for AA amyloidosis using serum amyloid P component scintigraphy.
Main Results:
- Identified pyrin/marenostrin mutations in most FMF patients, with 17/23 classical/probable FMF patients being homozygotes or compound heterozygotes.
- Discovered two new mutations (T6811 and delta M694).
- Found AA amyloidosis in nine patients, independent of specific genotype; no mutations were found in three of four possible FMF patients.
Conclusions:
- Pyrin/marenostrin genotyping is a valuable diagnostic test for FMF.
- Most FMF patients carry mutations in both pyrin/marenostrin alleles.
- Clinical interpretation of genotype results is crucial, as unidentified second mutations may occur.